Skip to Content

AN 322 (Niacin Extended-Release 750 mg)

Pill with imprint AN 322 is Orange, Capsule-shape and has been identified as Niacin extended-release 750 mg. It is supplied by Amneal Pharmaceuticals of New York, LLC.

Niacin is used in the treatment of high cholesterol; depression; hyperlipoproteinemia type iv, elevated vldl; niacin deficiency; hyperlipoproteinemia (and more), and belongs to the drug classes miscellaneous antihyperlipidemic agents, vitamins. Risk cannot be ruled out during pregnancy. Niacin 750 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for AN 322

Niacin extended-release

AN 322
750 mg
Rx and/or OTC
Drug Class:
Miscellaneous antihyperlipidemic agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Amneal Pharmaceuticals of New York, LLC
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.